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Abstract
Mg
2+ plays important roles in numerous cellular functions. Mitochondria take part in intracellular Mg
2+ regulation and the
Mg
2+ concentration in mitochondria affects the synthesis of ATP. However, there are few methods to observe Mg
2+ in
mitochondria in intact cells. Here, we have developed a novel Mg
2+–selective fluorescent probe, KMG-301, that is functional
in mitochondria. This probe changes its fluorescence properties solely depending on the Mg
2+ concentration in
mitochondria under physiologically normal conditions. Simultaneous measurements using this probe together with a probe
for cytosolic Mg
2+, KMG-104, enabled us to compare the dynamics of Mg
2+ in the cytosol and in mitochondria. With this
method, carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP)–induced Mg
2+ mobilization from mitochondria to
the cytosol was visualized. Although a FCCP–induced decrease in the Mg
2+ concentration in mitochondria and an increase
in the cytosol were observed both in differentiated PC12 cells and in hippocampal neurons, the time-courses of
concentration changes varied with cell type. Moreover, the relationship between mitochondrial Mg
2+ and Parkinson’s
disease was analyzed in a cellular model of Parkinson’s disease by using the 1-methyl-4-phenylpyridinium ion (MPP
+). A
gradual decrease in the Mg
2+ concentration in mitochondria was observed in response to MPP
+ in differentiated PC12 cells.
These results indicate that KMG-301 is useful for investigating Mg
2+ dynamics in mitochondria. All animal procedures to
obtain neurons from Wistar rats were approved by the ethical committee of Keio University (permit number is 09106-(1)).
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Introduction
The magnesium ion (Mg
2+) is an essential cation for
maintaining proper cellular activities. For example, Mg
2+ is an
essential cofactor for hundreds of enzymes [1,2], the intracellular
concentration of Mg
2+ ([Mg
2+]i) regulates several types of ion
channels [3,4], and Mg
2+ plays an important role in energy
metabolism [5,6]. [Mg
2+]i is usually maintained in the range of
0.5–0.7 mM, not only by Mg
2+ transport across the cell
membrane, but also by intracellular buffering and compartmen-
tation into organelles in the majority of mammalian cells [7]. In
diseased states, or under the administration of certain hormonal
stimuli or cAMP signaling agents, remarkable alterations in
[Mg
2+]i are observed [2,8,9]. Therefore, it is important to
investigate cellular Mg
2+ transport and concentration changes in
the cytosol and in organelles to better understand intracellular
signaling and the pathogenesis of some types of diseases. Because
of the absence of Mg
2+ selective indicators, however, the changes
in [Mg
2+]i in cells and organelles are still not well understood.
Commercially available fluorescent Mg
2+ probes are also sensitive
to changes in the intracellular Ca
2+ concentration, and therefore,
those probes are often used as Ca
2+ indicators [10,11,12]. In our
group, novel Mg
2+ selective fluorescent probes, the KMG series,
have been developed [13,14]. These probes are selective for Mg
2+
and other ions present at physiological concentrations have no
effect on their fluorescence. Using these probes, changes in
[Mg
2+]i were measured in many types of cells [15,16,17], and it
was demonstrated that mitochondria play an important role in
intracellular Mg
2+ dynamics [18,19].
Mitochondria are the organelles responsible for the cellular
energy metabolism, and it was reported that ATP synthesis in
mitochondria is regulated by the Mg
2+ concentration in
mitochondria [20]. Mitochondria accumulate Mg
2+ using their
inner membrane potential via Mrs2, which is a Mg
2+–selective
channel expressed in the mitochondrial inner membrane [21,22].
Mitochondria also transport Mg
2+ bound to ATP via the ATP–
Mg/Pi carrier in the mitochondrial inner membrane. This
exchanger mediates the electroneutral influx and efflux of ATP–
Mg in exchange for Pi [23]. Because the depolarization of the
mitochondrial inner membrane potential induces the release of
Mg
2+ from mitochondria [18], it is likely that the dysfunction of
mitochondria and the disorder of cellular Mg
2+ regulation are
strongly related. Actually, such malfunctions are reported in many
neuronal diseases, such as migraine, Alzheimer’s disease and
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23684Parkinson’s disease (PD) [24,25,26,27]. These evidences indicate
that the investigation of Mg
2+ concentration changes in mito-
chondria is important to understand the detailed mechanisms in
intracellular signaling and pathogenesis of such diseases. However,
few techniques are available for investigating magnesium concen-
tration changes in mitochondria.
In this study, we have developed a novel Mg
2+–selective
fluorescent probe based on the rhodamine skeleton (KMG-301),
and shown that it is functional inside mitochondria in intact cells.
Using this probe, Mg
2+ transport across the mitochondrial
membrane and Mg
2+ concentration changes in the early phases
of a cellular model of PD were analyzed.
Results and Discussion
Molecular design
In this work, a Mg
2+–selective fluorescent probe that is
functional in mitochondria was designed and synthesized. The
rhodamine skeleton was selected as the chromophore, and a
charged-beta-diketone moiety as the binding site for Mg
2+
coordination. Rhodamine with its cationic charge is known to
localize to mitochondria because of their negative membrane
potential [28]. Our previous work has shown that the charged-
beta-diketone binding site has high selectivity for Mg
2+ [29].
Several novel Mg
2+–selective fluorescent probes with the charged-
bata-diketone binding site introduced in the form of an a-keto acid
have been developed [13,14,30]. These probes enable the
measurement of [Mg
2+]i with high selectivity and sensitivity,
whereas commercially available Mg
2+ indicators are less selective
over Ca
2+ [31]. Since Ca
2+ concentrations in mitochondria are
higher than in the cytosol and can vary over a wide range [32], it is
important that Mg
2+ indicators used in mitochondria are not
affected by these Ca
2+ concentration changes. Therefore, the
highly Mg
2+–selective charged-beta-diketone binding site was
conjugated to the 9 position of the rhodamine skeleton, resulting
in the novel probe KMG-301. This structure shows photoinduced
electron transfer (PET)–type OFF-ON responses in the presence of
Mg
2+ ions. The synthetic scheme is shown in Figure 1.
Molecular properties of KMG-301
The absorbance and fluorescence spectra of KMG-301 were
measured at a probe concentration of 5 mM in HEPES buffer
(pH 7.2). Whereas 100 mM of Mg
2+ did not alter the absorbance
spectrum of KMG-301, it induced a 45-fold increase in fluorescence
emission intensity compared to the ion-free condition (Figure 2A).
The dissociation constant of this probe for Mg
2+ was found to
be 4.5 mM, which is a suitable value for detecting Mg
2+ in
mitochondria. The fluorescence quantum yield (Wfl)a n dt h e
molar extinction coefficient (e) were determined as 0.15 and
42100 M
21cm
21, respectively. Although KMG-301 showed a 3-
fold fluorescence increase in the presence of 100 mM Ca
2+,n o
fluorescence increase was observed at 1 mM Ca
2+ (Figure 2B).
Therefore, the physiologically relevant Ca
2+ concentrations
(,100 mM) do not affect the fluorescence of KMG-301. Physiological
concentration ranges of Na
+ and K
+ also have no effect on the
fluorescence of KMG-301, both in the absence or presence of Mg
2+
(Figure2B and C). Moreover, other divalent cations did not influence
the fluorescence signal at physiological concentrations (Figure 2C).
KMG-301 was found to be sensitive to 1 mM of Ni
2+ and Zn
2+
(Figure S1). But in a physiological environment, concentrations of
divalent cations other than Mg
2+ and Ca
2+ are below 1 mMw h e r e a s
that of Mg
2+ is 0.5–0.7 mM. Therefore, it can be concluded that
KMG-301 is only sensitive to Mg
2+ under intracellular and
intramitochondrial conditions. The ion-free and Mg-bound fluores-
cence emission peaks of KMG-301 showed only a weak response to
pH in the range of pH 6.5–9 (Figure 2D). The mitochondrial pH
value is considered to be around 8.6. As a consequence, it can be
concluded that pH (.6.0) and any other cations do not interfere with
the measurement of Mg
2+ concentrations using KMG-301 under
physiologically normal intracellular conditions.
The localization of KMG-301 to mitochondria was confirmed
in differentiated PC12 cells and hippocampal neurons. KMG-301
in the acetoxy methyl esterified form (KMG-301AM) (Figure 1)
was applied to these cells. The localization of KMG-301
corresponded with that of MitoTracker Green FM (Figure 2E).
This data indicates that KMG-301 was successfully localized in
mitochondria in intact cells.
Figure 1. Organic synthesis of KMG-301.
doi:10.1371/journal.pone.0023684.g001
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To confirm that KMG-301 is able to indicate changes in
mitochondrial Mg
2+ concentration ([Mg
2+]mito), isolated mito-
chondria from PC12 cells were stained with KMG-301AM.
Increasing the Mg
2+ concentration around mitochondria from
0 mM to 1 mM induced a noticeable increase of KMG-301
fluorescence. A further increase in Mg
2+ concentration around
mitochondria from 1 mM to 5 mM induced a further increase in
KMG-301 fluorescence (Figure 3A). In previous studies, we have
demonstrated that carbonyl cyanide p-(trifluoromethoxy) phenyl-
hydrazone (FCCP) induces Mg
2+ release from mitochondria in
PC12 cells [18]. Administration of FCCP induced a gradual
decrease in KMG-301 fluorescence in mitochondria isolated from
PC12 cells (Figure 3B). The time-course of this KMG-301
fluorescence decrease was similar to that of the FCCP-induced
decrease in mitochondrial membrane potential in mitochondria
Figure 2. Properties of KMG-301. (A) Absorbance and normalized fluorescence emission spectra of KMG-301 at different Mg
2+ concentrations.
Spectra were measured at a probe concentration of 5 mM at pH 7.2 (100 mM HEPES buffer). Mg
2+ concentrations are 0 (black line) and 100 mM (gray
line) for absorbance spectra, and from 0 mM to 100 mM for fluorescence spectra (excitation 540 nm). (B) Relative fluorescence intensities of KMG-301
in the presence of different cations in concentrations ranging from 0.1 to 200 mM (Mg
2+,C a
2+), and from 0.1 to 500 mM (Na
+,K
+) normalized by the
value in ion–free solution. (C) Metal ion selectivity of KMG-301 at physiological concentrations. Ni
2+,M n
2+,C o
2+,C u
2+,Z n
2+,F e
2+ and Fe
3+ were added
at 1 mM. Ca
2+ was added at 1 mM. Na
+,K
+ and Mg
2+ were added at 100 mM. The concentrations were chosen according to the physiological
conditions. Fluorescence intensities were normalized by the value in ion–free solution. (D) Effect of the pH on the fluorescence intensity of KMG-301
was measured at pH 5.5–6.5 (in 100 mM MES buffer) and pH 7.0–9.5 (in 100 mM HEPES buffer), with 0 mM or 100 mM of Mg
2+. The fluorescence
intensities were normalized by the value at pH 7.0 with 100 mM of Mg
2+. (E) Localization of KMG-301 to mitochondria was confirmed in differentiated
PC12 cells (upper) and rat hippocampal neurons (bottom). The localization of the fluorescence of KMG-301 (red) and MitoTracker Green FM (green)
were corresponded to each other in both cells (merge). The scale bars indicate 10 mm.
doi:10.1371/journal.pone.0023684.g002
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from rat brain, FCCP also induced a gradual decrease in the
fluorescence of KMG-301, whereas it induced a rapid decrease in
the fluorescence of TMRE (Figure S2). It was confirmed that the
FCCP-induced decrease in KMG-301 fluorescence was not caused
by leaking of the dye from mitochondria. When the membrane
potential partially recovered after washout of FCCP from
mitochondria isolated from PC12 cells, the KMG-301 fluores-
cence also recovered significantly (Figure 3C and D). Mitochon-
dria accumulated Mg
2+ depending on the increase in their
membrane potential, and KMG-301 could successfully detect
the increase in Mg
2+ concentration in mitochondria. This data
allows to conclude that KMG-301 changes its fluorescence in
response to the changes in [Mg
2+]mito.
KMG-301 responds to Mg
2+ concentration changes in
mitochondria in intact cells
Mrs2 is known as a Mg
2+–selective channel expressed in the
mitochondrial inner membrane, and mitochondria accumulate
Mg
2+ via this channel depending on an electrochemical gradient
[33]. To confirm that KMG-301 accumulates inside mitochondria
in intact cells, changes in probe fluorescence in normal cells and in
cells with suppressed Mrs2 expression levels were compared.
Suppression of the Mrs2 expression levels was performed by
transfection of a vector encoding both emerald GFP (EmGFP) and
a miR RNAi for Mrs2 to PC12 cells (Figure S3). Because miR
RNAi–expressing cells also express EmGFP, fluorescence changes
of KMG-301 were measured only in EmGFP expressing cells. An
increase in the extracellular Mg
2+ concentration from 0 mM to
10 mM induced a remarkable increase in cytosolic Mg
2+
concentration ([Mg
2+]cyto) and a fluorescence increase of KMG-
301 (Figures S4 and 4A gray line). This change in fluorescence of
KMG-301 was caused by the change in [Mg
2+]mito not by that in
[Mg
2+]cyto because no significant increase in fluorescence was
observed in mitochondria-free areas (Figure S5). This increase in
fluorescence of KMG-301 was significantly suppressed in miR
RNAi–expressing cells (Figure 4A black line and B). This data not
only indicates that KMG-301 was successfully internalized in
mitochondria and detected the changes in [Mg
2+]mito in intact
cells, but also that Mrs2 plays an important role in Mg
2+
accumulation in mitochondria.
Figure 3. KMG-301 detects the changes in Mg
2+ concentration in isolated mitochondria. (A) Time-course and pseudo-colored images of
the change in the fluorescence of KMG-301 in isolated mitochondria stained with KMG-301AM. Stepwise increases in the extramitochondrial Mg
2+
concentration induced increases in the fluorescence of KMG-301 in mitochondria. This indicates that Mg
2+ absorption in mitochondria was measured
successfully with KMG-301. The scale bar indicates 10 mm. (B) Time-course and pseudo-colored images of the change in the fluorescence of KMG-301
in response to 5 mM FCCP. The FCCP–induced release of Mg
2+ from mitochondria was observed successfully. (C) Mean fluorescence intensities of
TMRE before stimuli, 5 min after FCCP treatment and 10 min after washout in isolated mitochondria from PC12 cells. The membrane potential
partially recovered after washout of FCCP. (D) Mean fluorescence intensities of KMG-301 before stimuli, 5 min after FCCP treatment and 10 min after
washout. Fluorescence of KMG-301 was increased upon repolarization of the mitochondrial membrane potential. This data indicates that the
fluorescence of KMG-301 is responding to the changes in [Mg
2+]mito. The error bars indicate SEM.
doi:10.1371/journal.pone.0023684.g003
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mitochondria upon depolarization of the mitochondrial mem-
brane potential. Rhodamine123 was used in a control experiment.
Rhodamine 123 is a cell–permeable cationic fluorescent dye and
widely used as a marker for mitochondria. This probe accumulates
in the matrix of mitochondria dependent on their membrane
potential. Upon depolarization of the mitochondrial membrane
potential, Rhodamine 123 is released into the cytosol and the
extracellular medium. Whereas FCCP induced a decrease in the
fluorescence intensity of Rhodamine 123 in the cell body (presence
of mitochondria), it induced an increase in the nucleus area (no
mitochondria; Figure 5A and C). This indicates that the probe
released from mitochondria caused an increase in the probe
concentration in the cytosol and the nucleus, accompanied by a
fluorescence increase in the same areas. On the other hand,
whereas FCCP also induced a decrease in the fluorescence
intensity of KMG-301 in the cell body, no increase in fluorescence
was observed in the nucleus area of PC12 cells (Figure 5B and C).
This indicates that KMG-301 accumulated in mitochondria and
was not released from mitochondria by depolarization of the
mitochondrial membrane potential. KMG-301AM successfully
accumulates in mitochondria and is then hydrolyzed to KMG-
301. Since the mitochondrial membrane is impermeable to KMG-
301, it is not released upon depolarization of the mitochondrial
membrane potential. Therefore, it can be concluded that KMG-
301 is a Mg
2+–selective fluorescent probe functional in mitochon-
dria in intact cells. To the best of our knowledge, this is the first
reported method for visualization of changes in [Mg
2+]mito in
intact cells.
Imaging of intracellular Mg
2+ mobilization from
mitochondria
Because the excitation and emission spectra of KMG-301 are
different from those of the cytosolic Mg
2+ probe KMG-104, it is
possible to simultaneously observe the fluorescence of both probes.
The interaction between the cytosolic and mitochondrial Ca
2+
concentrations was observed and analyzed with simultaneous use
of fura-2 and rhod-2 [34,35]. These studies have clarified the
contribution of mitochondria to Ca
2+–buffering and Ca
2+
mobilization. In this study, Mg
2+ transport across the mitochon-
drial membrane was visualized by simultaneous application of
KMG-104AM and KMG-301AM.
In our previous study, FCCP–induced Mg
2+ release from
mitochondria was shown by comparing the changes in [Mg
2+]cyto
around mitochondria with those in areas with no mitochondria
[18]. Because KMG-301 allows to measure the changes in
[Mg
2+]mito directly, in this study, the changes in [Mg
2+]cyto and
[Mg
2+]mito were measured Moreover, Mg
2+ dynamics were
compared in differentiated PC12 cells and in hippocampal
neurons. In differentiated PC12 cells, [Mg
2+]cyto increased for
1 min after FCCP administration and maintained a high value,
whereas [Mg
2+]mito decreased for more than 4 minutes after
FCCP treatment (Figures 6A and B). In hippocampal neurons,
[Mg
2+]mito decreased only for 30 seconds after FCCP treatment
and kept its low value, although [Mg
2+]cyto increased for about 3
minutes (Figures 6C and D). Although the FCCP–induced
decrease in [Mg
2+]mito and increase in [Mg
2+]cyto were observed
both in differentiated PC12 cells and in hippocampal neurons, the
time-course of concentration changes varied with the cell type.
Because the time-courses of the depolarization of the mitochon-
drial membrane potential also varied with these cell types (Figure
S6), it could be one of the reasons for the variation in Mg
2+
transport. Moreover, these simultaneous measurements of changes
in [Mg
2+]cyto and [Mg
2+]mito revealed that the time-course of the
[Mg
2+]cyto increase and the [Mg
2+]mito decrease is not symmetric.
Since the Mg
2+ concentration is regulated by Mg
2+ entry, Mg
2+
efflux, buffering and compartmentation [7,36], it seems that those
differences in the Mg
2+ concentration changes are caused by the
cell type dependent differences in the balance of these mechanisms
and the intracellular compartments.
Mg
2+ entry into cells is mediated primarily by ion channels.
Recently, many types of Mg
2+–permeable channels have been
identified [4,37]. Some of them alter their expression levels or
localization based on the environmental Mg
2+ concentration.
Buffering and muffling of increased [Mg
2+]cyto are carried out
mainly by Mg
2+ extrusion via the Na
+/Mg
2+ exchanger and
Mg
2+ binding to ATP [38]. In PC12 cells, Mg
2+ is extruded via
the Na
+/Mg
2+ exchanger after FCCP administration [17]. It was
estimated that almost 1/3 of Mg
2+ muffling is due to Mg
2+
binding to ATP and another 1/3 is due to Na
+/Mg
2+ exchange
Figure 4. KMG-301 is functional in mitochondria in living cells. (A) Time-course of the changes in the fluorescence of KMG-301 in PC12 cells
expressing negative control miR RNAi (gray line) and miR RNAi for Mrs2 (black line). An increase in the extracellular Mg
2+ concentration from 0 mM to
10 mM induced an increase in the fluorescence of KMG-301 in PC12 cells expressing negative control miR RNAi. This increase in fluorescence was
significantly suppressed in PC12 cells expressing miR RNAi for Mrs2. (B) Comparison of the relative fluorescence intensities of KMG-301 1 minute after
the increase in extracellular Mg
2+ concentration. Both two miR RNAis significantly inhibited the increase in fluorescence of KMG-301. This data
indicates that KMG-301 was internalized in mitochondria and responded to changes in [Mg
2+]mito. The error bars indicate SEM. * indicates p,0.05,
and ** indicates p,0.01.
doi:10.1371/journal.pone.0023684.g004
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to result from sequestration by mitochondria. Here, it was
demonstrated that mitochondria also accumulate Mg
2+ (Figure 4).
Mrs2 plays an important role in this accumulation, because
knockdown of this protein significantly suppressed the increase in
[Mg
2+]mito (Figure 4). This result is consistent with a study on
isolated mitochondria [40]. It was also suggested that the
endoplasmic reticulum accumulates Mg
2+ [41]. The golgi
apparatus and endosomes have Mg
2+ transport proteins [37].
It could be possible that these organelles also participate in the
Mg
2+ buffering mechanism. [Mg
2+]mito is regulated by Mrs2 and
the ATP-Mg/Pi carrier in the mitochondrial inner membrane.
This antiporter electroneutrally mediates Mg
2+ transport de-
pending on the concentration gradients of Pi and ATP [23]. The
ATP concentration also affects the Mg
2+ concentration [38].
Moreover, it was reported that unidentified Mg
2+–binding
proteins exist in the intermembrane space of mitochondria
[42]. A balance of all those mechanisms controls the Mg
2+
concentrations in the cytosol and in mitochondria with the
possibility of further mechanisms being involved. Simultaneous
measurements of [Mg
2+]cyto and [Mg
2+]mito enable the compar-
ison of the Mg
2+ dynamics in these two compartments and
revealed that a collapse of the mitochondrial membrane
potential induces the perturbation of Mg
2+ concentrations in
the cytosol and mitochondria.
PD inducible substance causes Mg
2+ decrease in
mitochondria
In dopaminergic cells, 1-methyl-4-phenylpyridinium ion
(MPP
+)–induced cell death is an excellent model of PD. Because
PC12 cells are dopaminergic cells, MPP
+–induced cell death in
PC12 cells has been widely used for investigations of the
mechanisms of neurodegeneration in PD [43,44]. Since a
mitochondria dysfunction was reported in PD patients and in
MPP
+–treated PC12 cells [44,45], it is likely that [Mg
2+]mito in
PD patients and MPP
+–treated cells were perturbed. To confirm
this hypothesis, changes in [Mg
2+]mito in response to MPP
+ were
measured in differentiated PC12 cells. After administration of
MPP
+,[ M g
2+]mito decreased gradually (Figure 7A). The time-
course of Mg
2+ release from mitochondria was similar to that of
the depolarization in the mitochondrial membrane potential
(Figure S7). MPP
+ in the range of 0.1–5 mM caused a Mg
2+
release from mitochondria in a dose–dependent manner
(Figure 7B). KMG-301 was bleached less than 5% in 10
minutes. In differentiated PC12 cells, 0.5–10 mM MPP
+ induces
cell death in a dose–dependent manner in 24 hours [46]. MPP
+–
induced Mg
2+ release from mitochondria was observed in a
concentration range consistent with the previous report. Because
MPP
+ acts as an inhibitor of the mitochondrial electron transfer
chain, the mitochondrial membrane potential collapsed in
MPP
+–treated PC12 cells [47]. Therefore, it is likely that
Figure 5. KMG-301 was not released from mitochondria upon depolarization of their membrane potential. (A) FCCP inducedadecrease
in fluorescence of rhodamine 123 in the cell body (presence of mitochondria, gray line). On the other hand, in the nucleus area (no mitochondria area),
anincreaseinfluorescenceintensitywasobserved(blackline).Itiscausedbythereleaseoftheprobefrommitochondriatothecytosol.Theselinesshow
the time-course average of 60 cells. (B) Whereas FCCP also induced a decrease in fluorescence of KMG-301 in the cell body (gray line), no increase in
fluorescence was observed in the nucleus area (no mitochondria area, black line). This data indicates that KMG-301 is not released from mitochondria
depending on the depolarization of their membrane potential. These lines show the time-course average of 43 cells. (C) Fluorescence images and
pseudo-colored images (F/F0) of non-differentiated PC12 cells stained with Rh123 and KMG-301. Upon FCCP administration, increases in fluorescence in
the nucleus area were observed only in Rh123 loaded cells. Red circles indicate the nucleus areas. The scale bar indicates 10 mm.
doi:10.1371/journal.pone.0023684.g005
Magnesium Imaging in Mitochondria
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23684MPP
+–induced Mg
2+ release from mitochondria was caused by a
decrease in the mitochondrial membrane potential, which is the
same mechanism as in the case of FCCP–induced Mg
2+ release
from mitochondria. Because a decline of mitochondrial function
is also observed in PD patients [45], this Mg
2+ release from
mitochondria might also occur in the neurons of PD patients. As
described above, Mg
2+ efflux from mitochondria results in Mg
2+
extrusion from cells via the Na
+/Mg
2+ exchanger, and thus in a
Figure 6. Simultaneous measurements of cytosolic and mitochondrial Mg
2+ concentration changes. (A) Time-course of the changes in
[Mg
2+]cyto (gray line) and [Mg
2+]mito (back line) was measured with KMG-104AM and KMG-301AM, respectively, in differentiated PC12 cells.
Administration of 5 mM FCCP induced a rapid increase in [Mg
2+]cyto and a gradual decrease in [Mg
2+]mito. (B) Pseudo–colored images of changes in
[Mg
2+]cyto (upper) and [Mg
2+]mito (bottom) were obtained at the indicated times. (C) Time-course of the changes in [Mg
2+]cyto (gray line) and
[Mg
2+]mito (back line) in hippocampal neurons. Administration of 5 mM FCCP induced a gradual increase in [Mg
2+]cyto and a rapid decrease in
[Mg
2+]mito. (D) Pseudo–colored images of changes in [Mg
2+]cyto (upper) and [Mg
2+]mito (bottom) were obtained at the indicated times. The error bars
indicate SEM. The scale bars indicate 10 mm.
doi:10.1371/journal.pone.0023684.g006
Figure 7. Putative PD inducible substance caused Mg
2+ release from mitochondria. (A) Time-course of the change in [Mg
2+]mito was
measured with KMG-301 in differentiated PC12 cells. Administration of 5 mM MPP
+ induced a gradual decrease of [Mg
2+]mito. The error bars indicate
SEM. (B) Comparison of the relative fluorescence intensities of KMG-301 10 minutes after the administration of MPP
+ at the indicated concentrations.
The [Mg
2+]mito decreased in a dose-dependent manner. The error bars indicate SEM.
doi:10.1371/journal.pone.0023684.g007
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2+. These observations imply that the
cellular Mg
2+ content is decreased in the early phase of MPP
+–
induced cell death in PC12 cells and during neurodegeneration
in PD.
In some studies, the deficiency of Mg
2+ and PD were found to
be closely related. PD–like dopaminergic neuronal loss was
observed in the rat brain after exposure to low magnesium intake
over generations [48]. It was also reported that the Mg
2+
concentration is lowered in the brain of PD patients [26]. These
reports suggest that low Mg
2+ uptake to neurons and/or Mg
2+
efflux from neurons are related to PD. Because Mg
2+ exerts a
preventive effect against MPP
+–induced neuronal degeneration
in rat dopaminergic neurons [49], the loss of cellular Mg
2+ seems
to accelerate the process of MPP
+–induced cell death and
neuronal degeneration in PD. Thus, Mg
2+ release from
mitochondria reported here seems to be a crucial event in the
model of PD.
Materials and Methods
Ethics statement
All animal procedures were approved by the ethical committee
of Keio University (permit number is 09106-(1)).
Synthesis
The organic synthesis of KMG-301 is described in the
supporting information (Text S1).
Measurement of probe properties
Absorption measurements were performed on a U-2001
spectrophotometer (HITACHI, Tokyo, Japan). For the determi-
nation of the fluorescence quantum yield (Wfl), rhodamine101
(Wfl=0.96) was used as fluorescence standard. Wfl and e were
measured in 100 mM HEPES buffer (pH 7.2) containing 100 mM
Mg
2+. Ion selectivity, pH sensitivity and fluorescence spectra were
measured using a SPECTRAMAX GEMINI XS fluorescence
microplate reader (Molecular Devices, Mountain View, CA,
USA). The fluorescence of 5 mM KMG-301 was measured in
100 mM HEPES buffer (pH 7.2) with or without metal ions to
estimate the ion selectivity. The effect of pH on the fluorescence of
5 mM KMG-301 was measured in 100 mM MES buffer (pH 5.5–
7.0) or 100 mM HEPES buffer (pH 7.5–9.5) with or without
100 mM Mg
2+. Excitation was performed at 540 nm and
fluorescence emission was measured from 570 to 700 nm. The
fluorescence emission intensity at 590 nm was used as the signal in
the various experiments.
Cell culture
The primary culture of hippocampal neurons was prepared
from day 17–19 embryonic Wistar rats (Charles River Laborato-
ries Japan, Tokyo, Japan). Hippocampi were excised and
submerged in ice-cold PBS(-). The hippocampal neurons were
dissociated using dissociation solution (Sumitomo Bakelite Co.,
Tokyo, Japan), and plated on poly-D-lysine (PDL; Sigma-Aldrich,
St. Louis, MO, USA)–coated glass bottom dishes (Iwaki, Tokyo,
Japan), and cultured in neurobasal medium supplemented with
B-27, 2 mM L-glutamine, 50 U/ml penicillin and 50 mg/ml
streptomycin (all from Invitrogen, Carlsbad, CA, USA). Cultures
were maintained at 37uC in a humidified atmosphere of 5% CO2.
Cells were cultured for a minimum of seven days before
experimental use.
PC12 cells were obtained from RIKEN Tsukuba Institute, and
cultured in DMEM containing 10% horse serum, 5% FBS, 50 U/
ml penicillin and 50 mg/ml streptomycin. For experimental use,
cells were cultured on PDL–coated glass bottom dishes. In some
experiments, cells were differentiated by culturing in serum–free
medium with 50 ng/ml NGF for 5 days.
Isolation of mitochondria
Mitochondria were isolated from PC12 cells and rat brain (E19)
using the Mitochondria Isolation Kit (BioChain Institute Inc.,
Gibbstown, NJ, USA). In short, cells were suspended in
Mitochondria Isolation Buffer and homogenized with a Dounce
homogenizer on ice. The homogenate was centrifuged 6006g for
10 min at 4uC, and the supernatant was further centrifuged at
12,0006g for 15 min at 4uC. The pellet was suspended in
Mitochondria Storage Buffer and placed on Cell-Tak (BD
Biosciences, Franklin Lakes, NJ, USA)–coated glass bottom dishes,
and incubated 30–90 min on ice to embed on glass.
Fluorescence measurements
For optical imaging, 20 mM KMG-301AM was applied to cells
in Hanks’ balanced salt solutions (HBSS) containing (in mM):
NaCl, 137; KCl, 5.4; CaCl2, 1.3; MgCl2, 0.5; MgSO4, 0.4;
Na2HPO4, 0.3; KH2PO4, 0.4; NaHCO3, 4.2; D-glucose, 5.6;
HEPES, 5 (pH adjusted to 7.4 with NaOH) for 10 min on ice, so
that hydrolysis of the acetoxymethyl ester by esterase present in the
cytosol would be avoided [50]. Then, the cells were washed twice
with HBSS and incubated for 15 min at 37uC to allow for
complete hydrolysis of the acetoxymethyl ester form in mitochon-
dria. For the simultaneous use of KMG-104AM and KMG-
301AM, cells were incubated with 5 mM KMG-104AM in HBSS
for 30 min at 37uC, and then stained with KMG-301AM. For
simultaneous use of KMG-301AM and MitoTracker Green FM,
KMG-301–loaded cells were incubated with 5 nM MitoTracker
Green FM for 10 min at 37uC, and then the cells were washed
twice with HBSS. Rhodamine 123 was used at 100 nM, which is a
non-quenching concentration. Cells were incubated with Rhoda-
mine 123 in HBSS for 30 min at 37uC. Then the cells were
washed twice with HBSS and incubated for 15 min in 37uC.
Isolated mitochondria were incubated with 20 mM KMG-
301AM in Mitochondria Imaging Buffer (MIB) containing (in
mM): KCl, 125; K2HPO4, 2; MgCl2, 1; HEPES, 5; EDTA, 0.02
(pH adjusted to 7.2 with KOH) or Mg
2+-free MIB (without
MgCl2) for 20 min at 37uC. Then, mitochondria were washed
twice with MIB and further incubated for 15 min at 37uC.
Fluorescence imaging experiments were performed using a
confocal laser scanning microscope system (FluoView FV1000;
Olympus, Tokyo, Japan) mounted on an inverted microscope
(IX81; Olympus) with 406 and 606 oil–immersion objective
lenses. KMG-301 was excited at 559 nm from a laser diode, and
the signal was observed at 600–700 nm. In the simultaneous
measurement, KMG-104 and KMG-301 were excited at 488 nm
from an Argon laser and 559 nm, respectively. Fluorescence was
separated using a 560 nm dichroic mirror and observed at 500–
545 nm and 600–700 nm, respectively. Fluorescent images were
acquired and analyzed with the FluoView software package
(Olympus). Fluorescence differences were calculated as the mean
intensity over a defined region of interest (ROI) containing the cell
body of each cell.
Knockdown of Mrs2 protein
miR RNAi–mediated knockdown was performed using the
BLOCK-iT
TM PolII miR RNAi Expression Vector Kit with
EmGFP (Invitrogen). The miR RNAis sequences are listed in the
supporting information. The expression vector was transfected to
PC12 cells by electroporation using Neon (Invitrogen). Experi-
ments were performed 4-days after transfection. The expression of
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fluorescence measurements, the fluorescence of KMG-301 was
observed only in EmGFP–expressing cells.
Statistical analyses
Significant differences were determined by using Tukey’s test for
multiple comparisons. The p values less than 0.05 were considered
as being significantly different.
Supporting Information
Figure S1 Ion selectivity of KMG-301. The same concen-
tration (1 mM) was used for investigating the relative fluorescence
intensity. KMG-301 is also sensitive to Ni
2+ and Zn
2+ but not to
Ca
2+,N a
+ and K
+ at equimolar concentrations. Undre the
physiological condition, the concentrations of Ni
2+,M n
2+,C o
2+
and Zn
2+ are less than 1 mM, whereas that of Mg
2+ is 0.5–
0.7 mM. Therefore, KMG-301 is sensitive only to Mg
2+ under
intracellular and intramitchondrial conditions.
(TIF)
Figure S2 FCCP-induced depolarization and decrease
in KMG-301 fluorescence in isolated mitochondria. (A)
Time-course of FCCP-induced depolarization in isolated mito-
chondria from PC12 cells were measured with TMRE. The
mitochondrial membrane potential gradually decreased. (B) Time-
course of FCCP-induced depolarization in isolated mitochondria
from rat brain. The mitochondrial membrane potential rapidly
decreased after administration of FCCP. (C) Time-course of
FCCP-induced decrease in KMG-301 fluorescence in isolated
mitochondria from the rat brain. The fluorescence of KMG-301
gradually decreased and its time-course is different from the rapid
depolarization of the mitochondrial membrane potential. The
error bars indicate SEM.
(TIF)
Figure S3 Knockdown of Mrs2 in PC12 cells. Relative
expression levels of Mrs2 mRNA in PC12 cells transfected with
expression vectors for miR RNAi against Mrs2 (Mrs2 RNAi #1
and #2), negative control miR RNAi and non–transfected cells
were estimated with real-time PCR. In cells transfected with the
miR RNAi against Mrs2, the expression levels of Mrs2 mRNA
were suppressed. The efficiency of transfection of the vector to
PC12 cells ranged from 40–50%. The efficiencies of suppression
varied with the sequences of miR RNAi. Expression levels were
measured in 3-4 different samples and compared with that in non-
transfected cells. The error bars indicate SEM. * indicates p,0.05
estimated by using Tukey’s test.
(TIF)
Figure S4 Mg
2+ uptake into PC12 cells. The time-course of
the change in [Mg
2+]cyto (black line) and of the change in
fluorescence of KMG-301 (gray line) was simultaneously measured
in PC12 cells. Increasing the extracellular [Mg
2+] from 0 mM to
10 mM induced a remarkable increase in [Mg
2+]cyto and an
increase in the fluorescence of KMG-301([Mg
2+]mito). The error
bars indicate SEM.
(TIF)
Figure S5 The fluorescence intensity of KMG-301
changed in the ROIs of the cell body. Non-differentiated
PC12 cells expressing TagCFP-Mito (purchased from Evrogen,
Moscow, Russia) were stained with KMG-301. As shown in
Figure 4, an increase in extracellular Mg
2+ concentration from 0 to
10 mM induced an increase in the fluorescence of KMG-301.
Here, the fluorescence intensities of KMG-301 before and after
application of 10 mM Mg
2+ were compared in the ROI of the
whole cell body, which contains mitochondria, and in the
mitochondria-free area, which shows no fluorescence of
TagCFP-Mito. Significant increases in the fluorescence intensity
of KMG-301 were observed only in the ROIs of the whole cell
body (N=9, n=20). The error bars indicate SEM.
(TIF)
Figure S6 FCCP-induced depolarization of mitochon-
drial membrane potentials in differentiated PC12 cells
and hippocampal neurons. (A) The time-course of FCCP-
induced depolarization in PC12 cells was measured with TMRE.
The mitochondrial membrane potential gradually decreased. (B)
Time-course of FCCP-induced depolarization in hippocampal
neurons. The error bars indicate SEM.
(TIF)
Figure S7 MPP
+-induced depolarization of mitochon-
drial membrane potentials in differentiated PC12 cells.
The time-course of MPP
+-induced depolarization in differentiated
PC12 cells was measured with TMRE. The mitochondrial
membrane potential gradually decreased after MPP
+ application.
The error bars indicate SEM.
(TIF)
Text S1 The organic synthesis of KMG-301 and sup-
porting methods are included in this file.
(DOC)
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